DSP-5336
- Generic Name
- DSP-5336
- Drug Type
- Small Molecule
- Chemical Formula
- C33H43FN6O3
- CAS Number
- 2412555-70-3
- Unique Ingredient Identifier
- VW83Y2JLZ5
- Background
DSP-5336 is a menin inhibitor.
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
Phase 1
Recruiting
- Conditions
- Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute
- Interventions
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 362
- Registration Number
- NCT04988555
- Locations
- 🇺🇸
Hoag Family Cancer Center, Newport Beach, California, United States
🇺🇸Colorado Blood Cancer Institute, Denver, Colorado, United States
🇺🇸University of Miami, Miami, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath